glp-1 medications approved for type 2 diabetes 2025 In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with FDA-approved GLP-1 medications like Zepbound®

Coming off a GLP-1 too soonwhether due to cost, side effects, or reaching a goal weightcan lead to challenges like rebound weight gain, increased hunger, and shifts in blood sugar

doi: 10.1186/s12933-019-0942-x 102 LamCSPRamasundarahettigeCBranchKRHSattarNRosenstockJPratleyRet al

Some people find it helpful to mentally divide each zone into a grid pattern, moving systematically from one grid square to the next

In simple terms, this means your hair spends more time actively growing and less time preparing to shed

Evidence shows it can help preserve bone density, reduce fracture risk, and possibly benefit muscle and tendon health 22,23,24

DNA methylation estimation using methylation-sensitive restriction enzyme bisulfite sequencing (MREBS)